Carboxypeptidase E (CPE) deficiency in mice with the fat mutation have reduced stomach function.
An obese mouse model (Cpefat/Cpefat) that has hyperproinsulinemia and late onset obesity has been described. Cpefat/Cpefat mice have a missense mutation in carboxypeptidase E (CPE), a processing enzyme essential for production of biologically active endocrine and neuroendocrine peptides. We have reported previously that CPE activity was absent in the antrum of the stomach and that processing of progastrin to the amidated biologically active form of gastrin is reduced. Since gastrin is a major secretagogue for gastric acid secretion, the purpose of the present experiments was to examine gastric acid secretion in Cpefat/Cpefat mice. In addition, secretion of amidated gastrin in response to inhibition of acid secretion was tested in Cpefat/Cpefat. Both gastric acid and challenged gastrin secretion are reduced in Cpefat/Cpefat mice. We conclude that stomach CPE activity is essential for gastric secretory activity and for challenged gastrin release.
Gomez
P
P
Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555-0725, USA.
Hallberg
L
L
Greeley
G H
GH
D000818:Animals; D043423:Carboxypeptidase H; D002268:Carboxypeptidases / Q000172:deficiency* / Q000235:genetics; D015738:Famotidine / Q000494:pharmacology; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects / Q000201:enzymology*; D005755:Gastrins / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D051379:Mice; D008820:Mice, Obese; D020125:Mutation, Missense; D009765:Obesity / Q000201:enzymology / Q000235:genetics*; D011384:Proinsulin / Q000097:blood
D005755:Gastrins; D006635:Histamine H2 Antagonists; D015738:Famotidine; D011384:Proinsulin; D002268:Carboxypeptidases; D043423:Carboxypeptidase H